
(MedPage Today) — At the recent American Society of Clinical Oncology (ASCO) meeting, Roy Herbst, MD, PhD, of Yale Cancer Center in New Haven, Connecticut, reflected on how emerging innovations — from bispecific T-cell engagers to moving the…
Source link : https://www.medpagetoday.com/meetingcoverage/ascofuturefocusmm/116417
Author :
Publish date : 2025-07-08 18:56:00
Copyright for syndicated content belongs to the linked
Source.